期刊文献+

XJ-160病毒复制子型表达载体的构建 被引量:6

Construction of Replicon Expression Vector Derived from XJ-160 Virus
下载PDF
导出
摘要 XJ-160病毒是我国首次分离的辛德毕斯病毒,全基因组测序已经完成。本文利用该病毒全基因序列首先构建了全基因组cDNA克隆质粒,在此基础上,利用基因重组技术将病毒结构基因序列替换为含有多个单酶切位点的序列,得到复制子表达载体质粒pRepxj160。为验证载体的功能,将报告基因绿色荧光蛋白(EGFP)和β-半乳糖苷酶基因(lacZ)分别插入到载体的多克隆位点,得到两个表达质粒;经体外转录获得的转录体RNA转染BHK-21细胞后14h,可检测到报告基因的表达。结果表明我们构建的XJ-160病毒复制子型表达载体具有自主复制功能,可以表达异源基因。本研究为进一步开发具有我国自主知识产权的甲病毒载体奠定了基础。 XJ-160 is the first Chinese isolate of a Sindbis-like virus, and its genome was completely sequenced in our previous work. In this investigation, a full-length genomic cDNA clone was firstly constructed from RT-PCR products of the viral RNA. Then, the plasmid of replicon expression vector (pRepxj160) was derived from this cDNA clone replacing viral structural sequence with multiclonal sequence by DNA recombination technique.To verify function of this vector, reporter genes, EGFP and lacZ, were cloned into this plasmid, respectively. And RNA transcripted from expression plasmid was inducted into BHK-21 cell line, resulting in expression of green fluorescent protein and β -galactosidase 14 hours later. The results indicated that the replicon vector derived from XJ-160 virus was self-replicating and that the following gene expression was efficient. Our study settled the basis for developing alphavirus vector system with Chinese intellectual property.
出处 《中国病毒学》 CSCD 2003年第3期221-226,共6页 Virologica Sinica
基金 国家自然科学基金(No.39970037)
关键词 XJ-160病毒 复制子型表达载体 构建 辛德毕斯病毒 XJ-160 virus Sindbis virus, Alphavirus Replicon vector
  • 相关文献

参考文献11

  • 1李蕾,梁国栋,李富胜,周国林,付士红,何海怀,金奇,侯云德.XJ-160病毒为辛德毕斯病毒新亚型[J].病毒学报,2000,16(2):106-110. 被引量:13
  • 2Liang G D, Li L, Zhou G L, et al. Isolation and complete nucleotide sequence of a Chinese Sindbis-like virus[J]. J Gen Virol, 2000, 81,1347-1351.
  • 3Lundstrom K. Alphavirus vectors for gene therapy applications[J].Curt Gene Ther, 2001, 1: 19-29.
  • 4Lundstrom K. Alphavirus-based vaccines[J]. Curt Opin Mol Ther,2002, 4: 28-34.
  • 5Frolov I, Hoffman T A, Pragai B M, et al. Alphavirns-based expression vectors: strategies and applications[J]. Proc Nail Acad Sci USA, 1996, 93: 11371-11377.
  • 6Schlesinger S, Dubensky T W. Alphavirus vectors for gene expression and vaccines[J]. Curt Opin Biotechnol, 1999, 10: 434-439.
  • 7Vajdy M, Gardner J, Neidleman J, et al. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles[J]. J Infect Dis, 2001, 184: 1613-1616.
  • 8Caley I J, Betts M R, Irlbeck D M, et al. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector[J]. J Virol, 1997, 71 (4): 3031-8038.
  • 9Cheng W F, Hung C F, Hsu K E et al. Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion [J].Hum Gene Ther, 2002, 13: 553-568.
  • 10Daemen T, Regts J, Holtrop M, et al. Immunization strategy against cervical cancer involving an alphavirus vector expression high levels of a stable fusion protein of human papillomavirus 16 E6 and E7 [J].Gene Ther, 2002, 9: 85-94.

二级参考文献2

共引文献12

同被引文献157

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部